Bosh sahifaOGN • NYSE
add
Organon & Co
7,29 $
Seans yopilganidan keyin:(1,10%)-0,080
7,21 $
Yopilgan:8-dek, 19:22:38 (GMT-5) · USD · NYSE · Ogohlantirish
Yopilish kursi
7,14 $
Kunlik diapazon
7,10 $ - 7,34 $
Yillik diapazon
6,18 $ - 17,23 $
Bozor kapitalizatsiyasi
1,90 mlrd USD
Oʻrtacha hajm
7,70 mln
Narx/foyda
3,79
Dividend daromadliligi
1,10%
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,60 mlrd | 1,26% |
Joriy xarajat | 499,00 mln | -6,38% |
Sof foyda | 160,00 mln | -55,43% |
Sof foyda marjasi | 9,99 | -55,97% |
Har bir ulushga tushum | 1,01 | 16,09% |
EBITDA | 462,00 mln | 0,65% |
Amaldagi soliq stavkasi | 34,16% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 672,00 mln | -11,93% |
Jami aktivlari | 13,55 mlrd | 6,27% |
Jami passivlari | 12,65 mlrd | 3,16% |
Umumiy kapital | 906,00 mln | — |
Tarqatilgan aksiyalar | 259,98 mln | — |
Narxi/balansdagi bahosi | 2,05 | — |
Aktivlardan daromad | 6,84% | — |
Kapitaldan daromad | 9,55% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 160,00 mln | -55,43% |
Operatsiyalardan naqd pul | 264,00 mln | 87,23% |
Sarmoyadan naqd pul | -115,00 mln | -53,33% |
Moliyadan naqd pul | -76,00 mln | 2,56% |
Naqd pulning sof oʻzgarishi | 73,00 mln | 23,73% |
Boʻsh pul | 96,25 mln | 231,90% |
Haqida
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
Tashkil etilgan
1923
Sayt
Xodimlar soni
10 000
